Showing results (641-650 of 738) with videos related to
Sort By:
Pageof 74
Journal of Blood Medicine|July 26, 2017
Techniques used for the screening of hemoglobin levels in blood donors: current insights and future directionsRajendra Chaudhary, Anju Dubey, Atul SonkerJournal of Blood Medicine|August 4, 2017
Identification of people with acquired hemophilia in a large electronic health record databaseMichael Wang, Anissa Cyhaniuk, David L Cooper, et al.Journal of Blood Medicine|June 23, 2016
Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratioMustapha Haddouche, Warda Meziane, Zeyneb Hadjidj, et al.Journal of Blood Medicine|June 17, 2016
Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopeniaPrakash Vishnu, David M AboulafiaJournal of Blood Medicine|June 9, 2016
Strategies to encourage physical activity in patients with hemophilia to improve quality of lifeMiwa Goto, Hideyuki Takedani, Kazuhiko Yokota, et al.Journal of Blood Medicine|October 6, 2017
Reversing factor Xa inhibitors - clinical utility of andexanet alfaScott Kaatz, Hardik Bhansali, Joseph Gibbs, et al.Journal of Blood Medicine|November 25, 2020
Voluntary Blood Donation Among Bahir Dar University Students: Application of Integrated Behavioral Model, Bahir Dar, Northwest Ethiopia, 2020Eneyew Talie, Habtamu Wondiye, Nigus Kassie, et al.Journal of Blood Medicine|November 5, 2020
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and OutcomesLuca Castagna, Armando Santoro, Carmelo Carlo-StellaJournal of Blood Medicine|November 12, 2020
Plasma Folate Levels in Acutely Ill and Steady State Pediatric Sickle Cell Disease Patients in GhanaGeorge O Adjei, Abdul M Sulley, Bamenla Q Goka, et al.Journal of Blood Medicine|June 30, 2021
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)Claudia Djambas Khayat, Genadi Iosava, Irina Romashevskaya, et al.Pageof 74